Figure Technology Solutions, Inc. (FIGR) Q3 2025 Earnings Call Transcript — Neutral

FIGR   Seeking Alpha — November 18, 2025

Figure Technology Solutions, Inc. ( FIGR ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Michael Tannenbaum - CEO & Director Michael Cagney - Co-Founder & Executive Chairman Minchung Kgil - Chief Financial Officer Conference Call Participants Dan Dolev - Mizuho Securities USA LLC, Research Division James Yaro - Goldman Sachs Group, Inc., Research Division Patrick Moley - Piper Sandler & Co., Research Division Ryan Tomasello - Keefe, Bruyette, & Woods, Inc., Research Division Robert Wildhack - Autonomous Research US LP Daniel Fannon - Jefferies LLC, Research Division Craig Siegenthaler - BofA Securities, Research Division Presentation …

image for news Figure Technology Solutions, Inc. (FIGR) Q3 2025 Earnings Call Transcript

Paramount Skydance has formed an investment consortium with the sovereign wealth funds of Saudi Arabia, Qatar and Abu Dhabi to submit a total $71 billion bid for Warner Bros Discovery , Variety reported on Tuesday, citing sources familiar with the matter.

image for news Paramount preps $71 billion Warner Bros Discovery bid with Arab sovereign wealth funds, Variety reports

SAN FRANCISCO--(BUSINESS WIRE)--RSA Security today announced the general availability of its RSA Advisor for Admin Threats agent in Microsoft Security Copilot. “AI is the force multiplier for defenders, and when partners bring their agentic innovation into the Security Copilot ecosystem, the impact is exponential. Together, we're not just building tools—we're creating a new era of intelligent, collaborative cyber defense.” - Vasu Jakkal, Corporate Vice President, Microsoft Security. “We acceler.

image for news New RSA Agent for Admin Threats Now Generally Available in Microsoft Security Copilot

Mission Produce's U.K. Hub Gains Traction: Is Europe the Next Big Bet? — Positive

AVO   Zacks Investment Research — November 18, 2025

AVO's U.K. momentum fuels its Europe push, with rising demand and stronger retailer ties pointing to the company's next major growth frontier.

image for news Mission Produce's U.K. Hub Gains Traction: Is Europe the Next Big Bet?

U.S. airlines will see an impact of those slower bookings in their fourth quarter, which usually ties with second quarter and the start of the summer as their strongest for sales.

image for news People were booking their Thanksgiving flights at a fast clip. Here's why that ended.

PHILADELPHIA , Nov. 18, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against James Hardie Industries plc (NYSE: JHX) ("James Hardie" or the "Company") on behalf of investors who purchased James Hardie common stock or American Depositary Shares during the period of May 20, 2025 through August 18, 2025 (the "Class Period"). Investor Deadline: Investors who purchased James Hardie securities during the Class Period may, no later than December 23, 2025 , seek to be appointed as a lead plaintiff representative of the class.

image for news ATTENTION NYSE: JHX INVESTORS: Contact Berger Montague About a James Hardie Industries PLC Class Action Lawsuit

Singapore, Singapore--(Newsfile Corp. - November 18, 2025) - FingerMotion, Inc. (NASDAQ: FNGR) ("FingerMotion" or the "Company"), a mobile services, data, and technology company, today announces the next phase of its strategic roadmap, which focuses on expanding its technology platforms and monetizing the core competencies developed in China for broader regional markets. Over the past years, FingerMotion has built a strong foundation through its mobile recharge and top-up platform, data-driven analytics, and technology collaborations across multiple sectors.

image for news FingerMotion Announces Strategic Roadmap to Drive Regional Expansion and Shareholder Value

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”). Skye is a clinical stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Alleg.

image for news Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

WW International: First Normal Quarter Shows Signs Of Stability — Positive

WW   Seeking Alpha — November 18, 2025

WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.

image for news WW International: First Normal Quarter Shows Signs Of Stability

This TQQQ Chart Made Me Rethink Long-Term Leveraged Investing — Positive

TQQQ   Seeking Alpha — November 18, 2025

TQQQ is the cleanest, most liquid 3x Nasdaq-100 ETF, with tight spreads and a reasonable 0.82% yearly fee. TQQQ has outperformed QQQ and peers over the past 15 years, driven by a secular tech bull market and recently AI. This made me rethink my approach to leveraged investing. For short-term AI rebound trades, I still favor SOXL over TQQQ; semiconductors capture the most upside if an AI hype cycle is to reignite. Long term, I am considering TQQQ.

image for news This TQQQ Chart Made Me Rethink Long-Term Leveraged Investing

Celestica Expands AI Infrastructure Portfolio: Will it Fuel Revenues? — Positive

CLS   Zacks Investment Research — November 18, 2025

CLS' new SD6300 storage system targets soaring AI data needs with an ultra-dense design aimed at boosting performance and cost efficiency.

image for news Celestica Expands AI Infrastructure Portfolio: Will it Fuel Revenues?

Are You Looking for a Top Momentum Pick? Why TIM S.A. — Positive

TIMB   Zacks Investment Research — November 18, 2025

Does TIM S.A. Sponsored ADR (TIMB) have what it takes to be a top stock pick for momentum investors?

image for news Are You Looking for a Top Momentum Pick? Why TIM S.A.

Oric Pharmaceuticals (ORIC) Upgraded to Buy: Here's What You Should Know — Positive

ORIC   Zacks Investment Research — November 18, 2025

Oric Pharmaceuticals (ORIC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Oric Pharmaceuticals (ORIC) Upgraded to Buy: Here's What You Should Know

TriMas (TRS) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive

TRS   Zacks Investment Research — November 18, 2025

TriMas (TRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news TriMas (TRS) Upgraded to Strong Buy: What Does It Mean for the Stock?

First Bank (FRBA) Upgraded to Strong Buy: Here's What You Should Know — Positive

FRBA   Zacks Investment Research — November 18, 2025

First Bank (FRBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news First Bank (FRBA) Upgraded to Strong Buy: Here's What You Should Know

ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know — Positive

ADCT   Zacks Investment Research — November 18, 2025

ADC Therapeutics (ADCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know — Positive

ANIP   Zacks Investment Research — November 18, 2025

ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

image for news ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Ares Commercial Real Estate (ACRE) Upgraded to Buy: What Does It Mean for the Stock? — Positive

ACRE   Zacks Investment Research — November 18, 2025

Ares Commercial Real Estate (ACRE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Ares Commercial Real Estate (ACRE) Upgraded to Buy: What Does It Mean for the Stock?

What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock — Positive

JBIO   Zacks Investment Research — November 18, 2025

Jade Biosciences, Inc. (JBIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock

All You Need to Know About Virgin Galactic (SPCE) Rating Upgrade to Buy — Positive

SPCE   Zacks Investment Research — November 18, 2025

Virgin Galactic (SPCE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news All You Need to Know About Virgin Galactic (SPCE) Rating Upgrade to Buy